Prostatic body leakage protein (PSEP) detection reagent was selected into the 2018 Star Cup in vitro diagnostic annual excellent product award list

On January 2, 2019, the winners of the 2018 "Star" Cup Annual Excellent Papers for experiments and Annual excellent innovative products (instruments/reagents) for in vitro diagnosis were officially announced. According to the criteria for the benchmark evaluation, 28 reagents meeting the criteria for the evaluation were selected after strict preliminary review. According to the selection method of excellent innovative products (instruments/reagents) in vitro diagnosis, 7 excellent innovative reagents were selected after online voting, on-site defense and expert review. Among them, the global original prostatic body leakage protein detection reagent of Angko Biomedical Technology (Suzhou) Co., Ltd. was named among the award list with its excellent innovation advantages and outstanding achievements in the medical in vitro diagnosis industry.

  China in vitro diagnostic annual excellent innovative product - reagent Award

"Star" Cup China in Vitro diagnostic excellent innovative products (instruments/reagents) selection work is held once a year, by the National Health industry enterprise Management Association Experimental medicine Professional Committee, the National Health Industry Enterprise Management Association Medical inspection Industry branch, China Medical Device Industry Association in vitro diagnosis branch, China Experimental Medicine network · China in vitro diagnosis network. It aims to promote the innovation and development of the medical field, encourage the majority of scientific and technological personnel to innovate, innovate and innovate again, and launch the new innovation-driven engine at full speed to adapt to the national implementation of the innovation-driven development strategy.

About the enterprise

Angko Biomedical Technology (Suzhou) Co., Ltd. was established in Suzhou Science and Technology Venture Park in November 2010, is a Sino-foreign joint venture dedicated to the development of solid tumor diagnosis and treatment technology of high-tech biomedical professional. The company's scientific research team is led by famous scientists in the United States, and many Chinese and foreign experts who have been active in the field of international cancer research for a long time.

The company's first generation of products to new, non-invasive, urine-based prostatitis detection reagent, using ELISA detection method, the second generation using colloidal gold detection method, is in the clinical trial stage, followed by chemiluminescence and immunofluorescence detection projects will be listed one after another.

About the product

Prostatic body leakage protein (PSEP) test kit (enzyme-linked immunoassay) uses urine to specifically reflect prostatitis, and the product has global originality, filling the gap in the global in vitro diagnosis of chronic prostatitis.

Advantages of PSEP inspection

Global original: The world is relatively new detection indicators, fill the clinical gap, and have great application prospects

Widely used: not only suitable for general population screening, but also suitable for clinical diagnosis and efficacy detection

Simple and fast: sampling does not require the doctor to operate, improve the doctor's diagnosis efficiency

Non-invasive: urine detection, protect patient privacy, reduce patient sampling pain

Objective indicators: Laboratory indicators that do not rely on the subjective self-report of patients and the empirical judgment of doctors

Good specificity: specific reaction of prostate inflammation, can be used for the differential diagnosis of chronic prostatitis

High accuracy: After nearly 3 years of clinical big data verification, the sensitivity reached more than 88%, specificity reached more than 90%

Scope of clinical application of PSEP

Applicable departments: Urology, Andrology, reproductive center, Oncology, physical examination center, third party testing.

Suitable for: men who feel discomfort of urinary system (pelvic pain, frequent urination, urgent urination, insufficient urination); A large number of long-term smoking, drinking, staying up late, sitting for a long time and other bad habits of male population; Male population with sexual dysfunction; Sterile population; Urinary system discomfort, accompanied by anxiety, depression, insomnia, memory loss of men; Health screening of the normal population.